Celltrion, Inc. Completes EU Launch of 'Aptozma' 김새미 2026.01.30 오전 10:44 Celltrion Posts Record Q2 Results, Accelerates Global Pharma Ambitions 나은경 2025.07.24 오전 10:58 Celltrion Unfazed by U.S. Price Cuts, Tariffs Zymfentra Drag Tied to Insurance 송영두 2025.05.15 오후 03:23 Celltrion biosimilars expand dominance in Japan’s oncology market 임정요 2025.06.13 오전 10:11 Celltrion Posts Record-High Q2 Earnings with 235% Surge in Operating Profit 송영두 2025.07.21 오전 10:03 Celltrion’s Yuflyma Hits 24% in Europe on Direct Sales Strength 김새미 2025.08.04 오전 10:33 Celltrion Secures U.S. Manufacturing Base, Paving Way for Big Pharma Leap 송영두 2025.08.14 오후 02:55 Seo Jung-jin Reappointed, Celltrion Confident in 5 Trillion Sales Goal 송영두 2025.03.25 오후 05:08 Bio&Pharma Stocks: BL Pharmtech, Celltrion and Amicogen on the Rise 임정요 2025.02.27 오전 08:33 Trump Eyes Drug Tariffs-What It Means for K-Bio 김진수 2025.05.07 오전 10:16 더 보기 로딩중..
Remsima
Remsima
